Drug class

Antiviral-HIV PrEP Therapies

While "Antiviral-HIV PrEP Therapies" is an administrative or formulary grouping rather than a distinct pharmacological class, it describes antiretroviral medications utilized for human immunodeficiency virus type 1 (HIV-1) pre-exposure prophylaxis. Read more about Antiviral-HIV PrEP Therapies

20 drugs in this class 17 manufacturers

Advertisement

Drugs in Antiviral-HIV PrEP Therapies

Showing 10–18 of 20 drugs

Filter & compare in the drug finder → Opens the drug finder with Antiviral-HIV PrEP Therapies preselected. Add indication or manufacturer filters there.

About Antiviral-HIV PrEP Therapies.

While "Antiviral-HIV PrEP Therapies" is an administrative or formulary grouping rather than a distinct pharmacological class, it describes antiretroviral medications utilized for human immunodeficiency virus type 1 (HIV-1) pre-exposure prophylaxis.

These regimens encompass multiple mechanistic classes—most commonly nucleoside/nucleotide reverse transcriptase inhibitors, integrase strand transfer inhibitors, and capsid inhibitors—that interfere with essential viral replication cycles following potential exposure.

They are specifically indicated for HIV-negative adults and adolescents at substantial risk of acquiring HIV-1 infection through sexual contact or injection drug use.